Cargando…

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

In spite of impressive response rates in multiple cancer types, immune checkpoint inhibitors (ICIs) are active in only a minority of patients. Alternative strategies currently aim to combine immunotherapies with conventional agents such as cytotoxic chemotherapies. Here, we performed a study of PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grasselly, Chloé, Denis, Morgane, Bourguignon, Aurore, Talhi, Nolan, Mathe, Doriane, Tourette, Anne, Serre, Laurent, Jordheim, Lars Petter, Matera, Eva Laure, Dumontet, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190749/ https://www.ncbi.nlm.nih.gov/pubmed/30356816 http://dx.doi.org/10.3389/fimmu.2018.02100

Ejemplares similares

Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy
por: Denis, Morgane, et al.
Publicado: (2023)

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding
por: Hirz, Taghreed, et al.
Publicado: (2017)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
por: Chettab, Kamel, et al.
Publicado: (2023)

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity
por: Duong, Minh Ngoc, et al.
Publicado: (2015)

Characterization of T‐DM1‐resistant breast cancer cells
por: Sauveur, Juliette, et al.
Publicado: (2020)

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
por: Denis, Morgane, et al.
Publicado: (2020)

Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf
por: Cividini, Federico, et al.
Publicado: (2015)

PARP Inhibitors and Proteins Interacting with SLX4
por: Jordheim, Lars Petter
Publicado: (2023)

The cytosolic 5′-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells
por: Bricard, Gabriel, et al.
Publicado: (2017)

Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents
por: Chettab, Kamel, et al.
Publicado: (2015)

Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib
por: Geneste, A., et al.
Publicado: (2020)

Beta-hydroxyphosphonate ribonucleoside analogues derived from 4-substituted-1,2,3-triazoles as IMP/GMP mimics: synthesis and biological evaluation
por: Nguyen Van, Tai, et al.
Publicado: (2016)

Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines
por: Cadassou, Octavia, et al.
Publicado: (2021)

Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells
por: Hage-Sleiman, Rouba, et al.
Publicado: (2010)

Structural Insights into the Inhibition of Cytosolic 5′-Nucleotidase II (cN-II) by Ribonucleoside 5′-Monophosphate Analogues
por: Gallier, Franck, et al.
Publicado: (2011)

Immune checkpoint: The novel target for antitumor therapy
por: Jiang, Xianghu, et al.
Publicado: (2019)

Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway
por: Sauveur, Juliette, et al.
Publicado: (2018)

Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction
por: Barakat, Khaled H., et al.
Publicado: (2012)

Active Oxygen‐mediated Cytotoxic and Antitumor Actions of Streptococcal Cytotoxic Protein
por: Higuchi, Yoshihiro, et al.
Publicado: (1990)

New Derivatives of N-Hydroxybutanamide: Preparation, MMP Inhibition, Cytotoxicity, and Antitumor Activity
por: Balakina, Anastasia, et al.
Publicado: (2023)

Immune checkpoint inhibitors modulate the cytotoxic effect of chemotherapy in lung adenocarcinoma cells
por: Saar, Marika, et al.
Publicado: (2023)

Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
por: Ding, Zhi-Chun, et al.
Publicado: (2012)

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform
por: Conilh, Louise, et al.
Publicado: (2021)

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene
por: Galmarini, Carlos María, et al.
Publicado: (2004)

Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
por: Liu, Wenhui, et al.
Publicado: (2021)

FcγRIIB is a T cell checkpoint in antitumor immunity
por: Farley, Clara R., et al.
Publicado: (2021)

PD-1/PD-L1 Checkpoint Inhibitors Are Active in the Chicken Embryo Model and Show Antitumor Efficacy In Ovo
por: Wang, Yan, et al.
Publicado: (2022)

ESR of copper and iron complexes with antitumor and cytotoxic properties.
por: Antholine, W E, et al.
Publicado: (1985)

Linalool Exhibits Cytotoxic Effects by Activating Antitumor Immunity
por: Chang, Mei-Yin, et al.
Publicado: (2014)

Computational Verification of Large Logical Models—Application to the Prediction of T Cell Response to Checkpoint Inhibitors
por: Hernandez, Céline, et al.
Publicado: (2020)

New Potential Antitumor Pyrazole Derivatives: Synthesis and Cytotoxic Evaluation
por: Nitulescu, George Mihai, et al.
Publicado: (2013)

Cytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen Species
por: Sestili, Piero, et al.
Publicado: (2015)

Cytotoxic, Antitumor and Toxicological Profile of Passiflora alata Leaf Extract
por: Amaral, Ricardo G., et al.
Publicado: (2020)

Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors
por: Bagamanshina, Anastasia V., et al.
Publicado: (2019)

A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method
por: Guitton, Jérôme, et al.
Publicado: (2023)

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
por: Decaup, Emilie, et al.
Publicado: (2019)

Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
por: Qiao, Guanxi, et al.
Publicado: (2018)

TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunity
por: Bi, Jiacheng, et al.
Publicado: (2021)

Fucoidan-Supplemented Diet Potentiates Immune Checkpoint Blockage by Enhancing Antitumor Immunity
por: Yang, Juan, et al.
Publicado: (2021)

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
por: Archilla-Ortega, Adrià, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upihaa82ud0anv7u2v36588dva